IRadimed Corporation (IRMD)

IRadimed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	49.76	57.96	62	50.07	43.48
Short-Term Investments	0	0	0.5	1.91	2.77
Cash & Cash Equivalents	49.76	57.96	62.5	51.98	46.25
Cash Growth	-14.15%	-7.26%	20.25%	12.38%	34.54%
Receivables	12.22	13.27	5.14	4.57	7.29
Inventory	12.82	5.37	4.3	3.93	3.64
Other Current Assets	1.19	0.89	4.31	3.25	1.78
Total Current Assets	76	77.49	76.24	63.74	58.96
Property, Plant & Equipment	11.33	4.61	4.55	4.84	5.01
Goodwill and Intangibles	2.52	2.07	1.12	0.96	0.86
Other Long-Term Assets	2.3	1.35	0.97	1.53	1.9
Total Long-Term Assets	16.15	8.02	6.64	7.33	7.77
Total Assets	92.16	85.51	82.88	71.07	66.73
Accounts Payable	1.86	1.8	0.78	0.66	0.99
Deferred Revenue	5.36	4.75	4.23	4.25	4.3
Current Debt	0.43	0.29	0.28	0.26	0.24
Other Current Liabilities	8.68	1.71	1.53	-0.25	0.32
Total Current Liabilities	16.33	8.55	6.82	4.92	5.86
Long-Term Debt	1.62	1.91	2.21	2.46	2.72
Other Long-Term Liabilities	2.79	1.38	1.68	2.31	2.63
Total Long-Term Liabilities	4.41	3.29	3.88	4.76	5.35
Total Liabilities	20.74	11.84	10.71	9.68	11.2
Total Debt	2.04	2.21	2.48	2.72	2.96
Debt Growth	-7.36%	-11.15%	-8.58%	-8.15%	-
Retained Earnings	43.26	47.26	46.99	37.67	36.3
Comprehensive Income	0	0	0.02	0.04	0.03
Shareholders' Equity	71.42	73.67	72.17	61.38	55.52
Net Cash / Debt	47.72	55.76	60.02	49.26	43.29
Net Cash / Debt Growth	-14.41%	-7.10%	21.83%	13.79%	25.94%
Net Cash Per Share	3.75	4.41	4.77	3.94	3.53
Working Capital	59.67	68.94	69.42	58.82	53.1
Book Value Per Share	5.67	5.86	5.85	5.00	4.92

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).